Synergy Asset Management, LLC Amgen Inc Transaction History

Synergy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $5.5 Million - $6.12 Million	23,847 Added 233.59%	34,056 $8.29 Million
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $2.24 Million - $2.48 Million	10,209 New	10,209 $2.47 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $1.3 Million - $1.45 Million	-5,582 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $86,101 - $100,336	-388 Reduced 6.5%	5,582 $1.39 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $1.29 Million - $1.54 Million	5,970 New	5,970 $1.37 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Synergy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Synergy Asset Management, LLC with notifications on news.